Literature DB >> 22407259

Teriparatide's role in the management of bisphosphonate-associated osteonecrosis of the jaw.

G Subramanian, S Y P Quek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22407259     DOI： 10.1007/s00198-012-1951-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  9 in total

1.  Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.

Authors:  Ada Cheung; Ego Seeman
Journal:  N Engl J Med       Date:  2010-10-16       Impact factor: 91.245

2.  Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].

Authors:  Richard P Harper; Eugene Fung
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

3.  More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Kuo-Yang Tsai; Chin-Sheng Huang; Guan-Min Huang; Chen-Tung Yu
Journal:  J Rheumatol       Date:  2010-03       Impact factor: 4.666

4.  Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws.

Authors:  Y-D Kwon; D-W Lee; B-J Choi; J-W Lee; D-Y Kim
Journal:  Osteoporos Int       Date:  2012-01-05       Impact factor: 4.507

5.  The saxon bisphosphonate register - therapy and prevention of bisphosphonate-related osteonecrosis of the jaws.

Authors:  Marika Schubert; Ingolf Klatte; Wigbert Linek; Bianca Müller; Karli Döring; Uwe Eckelt; Alexander Hemprich; Uwe Berger; Jörg Hendricks
Journal:  Oral Oncol       Date:  2011-11-29       Impact factor: 5.337

Review 6.  A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution.

Authors:  Gayathri Subramanian; Harold V Cohen; Samuel Y P Quek
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-08-06

7.  Teriparatide and osseous regeneration in the oral cavity.

Authors:  Jill D Bashutski; Robert M Eber; Janet S Kinney; Erika Benavides; Samopriyo Maitra; Thomas M Braun; William V Giannobile; Laurie K McCauley
Journal:  N Engl J Med       Date:  2010-10-16       Impact factor: 91.245

8.  Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.

Authors:  David C Stanton; Edward Balasanian
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

9.  Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.

Authors:  Jang-Jaer Lee; Shih-Jung Cheng; Jiiang-Huei Jeng; Chun-Pin Chiang; Hon-Ping Lau; Sang-Heng Kok
Journal:  Head Neck       Date:  2010-03-22       Impact factor: 3.147
  9 in total
  2 in total

1.  Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Authors:  N Ersan; L J van Ruijven; A L J J Bronckers; V Olgaç; D Ilgüy; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

Review 2.  Osteochemonecrosis: an overview.

Authors:  John Hellstein
Journal:  Head Neck Pathol       Date:  2014-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.